Literature DB >> 19208205

Fear and loathing in the Caribbean: three studies of fear and cancer screening in Brooklyn's immigrant Caribbean subpopulations.

Nathan S Consedine1, Brenda A Adjei, David Horton, Andrew K Joe, Luisa N Borrell, Paul Michael Ramirez, Tracey Ungar, James M McKiernan, Judith S Jacobson, Carol Magai, Alfred I Neugut.   

Abstract

Entities:  

Year:  2009        PMID: 19208205      PMCID: PMC2638459          DOI: 10.1186/1750-9378-4-S1-S14

Source DB:  PubMed          Journal:  Infect Agent Cancer        ISSN: 1750-9378            Impact factor:   2.965


× No keyword cloud information.

Background

Anxiety, worry, and fear are among the most common emotional responses to the threat of disease and several studies have linked various fears to cancer preventive and detection behaviors. Cancer-related worry and fears about screening or its consequences are also characteristics that vary across ethnic groups and may be differentially linked to screening outcomes [1]. Limiting the utility of this growing literature are at least two key considerations. First, little attention has been paid to documenting variation in cancer-related fears among subpopulations of persons of African descent, despite evidence that (a) rates of screening may vary among both male [2] and female [3] immigrants from islands in the Caribbean living in the United States and (b) incidence rates for cancers such as those of the prostate may be very high in men from Jamaica [4], Guadaloupe [5] and Trinidad and Tobago [6], as well as in immigrant groups in both the United Kingdom [7] and United States [8]. Second, findings regarding the relations anxiety, cancer worry, and screening fear hold with screening behavior seen thus far have been inconsistent, in our view because anxieties stemming from different sources have different relations with behavior. In the emotions theory view, understanding the role of fear in health behavior in diverse groups is predicated on understanding the object or source of the fear [9-11] for the simple reason that anxiety motivates avoidance of particular elicitors [10,12]. Research conducted within the U54 Comprehensive Cancer Partnership between Long Island University and Columbia University has produced several studies documenting differences in breast and prostate cancer screening frequencies among Caribbean subpopulations living in Brooklyn, New York [1,12,13]. A major concentration in this program of behavioral research has investigated whether trait anxiety, cancer worry, and screening-related fears vary across Caribbean subpopulations and whether these highly differentiated emotional responses independently predict screening behavior in multivariate models [1,2,12-14]. Consistent with theory, we expected that fears pertaining to the screening context (e.g., fear of pain or the psychological implications of certain screens), would predict avoidance of the fear-inducing situation and thus be associated with less frequent screening. Conversely, where fears relate to the disease itself, greater fear should predict more frequent screening.

Methods

Because of our overarching interest in the links between cancer and cancer-screening-related fears and cancer screening behaviors among the diverse groups of men and women living in Brooklyn, New York, we combined data from three community-based studies. Although measures and samples varied somewhat across studies, each study investigated the link between emotions and screening outcome in ethnic groups that included immigrants from islands in the Caribbean. Because of our interest in examining differences within traditional racial categories, we used a combination of (a) self-categorization based on a the traditional racial categories offered in the US Census together with (b) information regarding country of origin. Allowing a combination of self-reported racial categorization (tapping aspects of identity and minority status) in concert with shared birthplace to influence groupings increases the likelihood that participants share cultural and developmental characteristics thought to form part of ethnicity [15]. We distinguished between Black men born in the United States (hereafter, U.S.-born African Americans), and those originating from countries in the English-speaking Caribbean (e.g., Trinidad & Tobago, Jamaica, Barbados). Immigrant and non-immigrant minority groups were contrasted with men self-identifying as "European or White/Non-Hispanic" who were born in the United States (hereafter, U.S.-born European American). In Study 1, stratified cluster-sampling was used to recruit 1364 women (aged between 50–70 years) from six ethnic groups: US-born African American, US-born European American, immigrants from islands in the English-speaking Caribbean (Jamaica, Barbados, Trinidad and Tobago), the Dominican Republic, Haiti, and Eastern Europe [1]. In Study 2, 180 US-born African American, US-born European American and immigrant Jamaican men (aged between 40–70 years) were recruited using convenience sampling [13]. In Study 3, 533 men (aged between 45–70 years) from four groups – US-born African American, US-born European American, and immigrant men from Jamaica and from Trinidad and Tobago – were recruited [12]. In each study, participants provided background data, reported on screening history for either breast or prostate cancer, and completed a measure of trait anxiety, cancer worry, and/or screening fears.

Results

As expected, we found differences among groups of African descent from the United States and the Caribbean. Although women from all groups screened at rates below those recommended, data from Study 1 showed that English-speaking Caribbean, Haitian and Dominican women screened less frequently than US-born African Americans and European Americans and that immigrant Eastern European women were also infrequent screeners (see Figure 1). Conversely, however, there were no differences in rates of self-reported prostate screening among men from the English-speaking Caribbean, US-born African Americans, or US-born European Americans in either Study 2 or Study 3. As expected, cancer-related emotional characteristics also varied across subpopulations (see Figure 2). Cancer worry was generally lower among women from the various Caribbean immigrant groups (Study 1) than it was among US-born African Americans or US-born European Americans. Fears regarding screening, however, varied somewhat differently. Fear of screening was higher among US-born African Americans and immigrant men from the English-speaking Caribbean (Studies 2 and 3) than among US-born European Americans. Consistent with the need to carefully measure fear-related constructs in the context of cancer behavior, however, our data also demonstrated that a specific fear related to concerns regarding threats to masculinity in the context of male screening strongly characterized the attitudes of men from the English-speaking Caribbean compared to the views of US-born European and US-born African Americans (Study 2). Finally, a combination of multiple regression and ANOVAs in each study showed that emotional characteristics independently predicted screening, in most cases even when background characteristics were controlled. Across studies, greater cancer worry predicted more frequent screening while fear of screening predicted less frequent screening.
Figure 1

Number of cancer screens in prior 10 years. DRE = digital rectal examination, PSA = prostate specific antigen test, Mamm = mammogram, CBE = clinical breast exam.

Figure 2

Emotion characteristics related to screening. Trait = trait anxiety, Worry = cancer worry, Scr. Fr. = screening fear, and Em. Con. = emasculation concern.

Number of cancer screens in prior 10 years. DRE = digital rectal examination, PSA = prostate specific antigen test, Mamm = mammogram, CBE = clinical breast exam. Emotion characteristics related to screening. Trait = trait anxiety, Worry = cancer worry, Scr. Fr. = screening fear, and Em. Con. = emasculation concern.

Conclusion

Data from three large-scale studies in Brooklyn, New York suggest that members of immigrant Caribbean subpopulations screen for breast and prostate cancer at very low rates; in most cases lower than those of either US-born African or US-born European Americans. Groups of Caribbean men and women also vary in the emotions they report regarding cancer and the screening process, generally revealing a pattern that is predictive of poorer screening. Coupled with the fact that emotion characteristics predicted screening outcomes even when controlling for other factors, data from these three studies suggest that the emotional responses Caribbean groups place them at risk for poor screening. Interventions that address these responses may offer the prospect of improving screening frequency in these disadvantaged groups.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

NSC and CM was involved in study design, analysis, interpretation/write up and critical revision of the manuscript. BA and DH in the analysis, interpretation and write up. AKJ, TU and LNB were involved in the interpretation and write up. PMR was part of the study design, analysis and interpretation/write up. JMM and AIN had part in the study design, analysis and critical revision whilst JSJ took part in critical revision.
  13 in total

1.  Diversity matters: Unique populations of women and breast cancer screening.

Authors:  Carol Magai; Nathan Consedine; Francine Conway; Alfred Neugut; Clayton Culver
Journal:  Cancer       Date:  2004-06-01       Impact factor: 6.860

2.  Stress versus discrete negative emotions in the prediction of physical complaints: does predictive utility vary across ethnic groups?

Authors:  Nathan S Consedine; Carol Magai; Elizabeth K Kudadjie-Gyamfi; Jean Kaluk Longfellow; Tracey M Ungar; Arlene R King
Journal:  Cultur Divers Ethnic Minor Psychol       Date:  2006-07

3.  The epidemiology of prostate cancer in Jamaica.

Authors:  F E Glover; D S Coffey; L L Douglas; M Cadogan; H Russell; T Tulloch; T D Baker; R L Wan; P C Walsh
Journal:  J Urol       Date:  1998-06       Impact factor: 7.450

4.  Prostate cancer incidence in guadeloupe, a French Caribbean archipelago.

Authors:  Stéphane Mallick; Pascal Blanchet; Luc Multigner
Journal:  Eur Urol       Date:  2005-03-09       Impact factor: 20.096

5.  Prostate-specific antigen screening in a high-risk population: lessons from the community and how they relate to large-scale population-based studies.

Authors:  Jeremy B Shelton; Daniel A Barocas; Frances Conway; Kathleen Hart; Kinloch Nelson; Lee Richstone; Ricardo R Gonzalez; Jay D Raman; Douglas S Scherr
Journal:  Urology       Date:  2005-05       Impact factor: 2.649

6.  Risk and presenting features of prostate cancer amongst African-Caribbean, South Asian and European men in North-east London.

Authors:  Frank Chinegwundoh; Mohamed Enver; Angela Lee; Vinod Nargund; Tim Oliver; Yoav Ben-Shlomo
Journal:  BJU Int       Date:  2006-12       Impact factor: 5.588

7.  An object lesson: source determines the relations that trait anxiety, prostate cancer worry, and screening fear hold with prostate screening frequency.

Authors:  Nathan S Consedine; Brenda A Adjei; Paul M Ramirez; James M McKiernan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07       Impact factor: 4.254

8.  Prostate cancer screening behavior in men from seven ethnic groups: the fear factor.

Authors:  Nathan S Consedine; Amy H Morgenstern; Elizabeth Kudadjie-Gyamfi; Carol Magai; Alfred I Neugut
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-02       Impact factor: 4.254

9.  Fear, knowledge, and efficacy beliefs differentially predict the frequency of digital rectal examination versus prostate specific antigen screening in ethnically diverse samples of older men.

Authors:  Nathan S Consedine; David Horton; Tracey Ungar; Andrew K Joe; Paul Ramirez; Luisa Borrell
Journal:  Am J Mens Health       Date:  2007-03

Review 10.  Fear, anxiety, worry, and breast cancer screening behavior: a critical review.

Authors:  Nathan S Consedine; Carol Magai; Yulia S Krivoshekova; Lynn Ryzewicz; Alfred I Neugut
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-04       Impact factor: 4.254

View more
  7 in total

1.  Mammography screening among Mexican, Central-American, and South-American women.

Authors:  Monica Rosales; Patricia Gonzalez
Journal:  J Immigr Minor Health       Date:  2013-04

Review 2.  Beyond the black box: a systematic review of breast, prostate, colorectal, and cervical screening among native and immigrant African-descent Caribbean populations.

Authors:  Nathan S Consedine; Natalie L Tuck; Camille R Ragin; Benjamin A Spencer
Journal:  J Immigr Minor Health       Date:  2015-06

3.  Correlates of Dominicans' Identification of Cancer as a Worrisome Health Problem.

Authors:  Alsacia L Sepulveda-Pacsi; Suzanne Bakken
Journal:  J Immigr Minor Health       Date:  2017-10

4.  Determinants of breast, cervical and colorectal cancer screening adherence in Mexican-American women.

Authors:  Patricia Gonzalez; Sheila F Castaneda; Paul J Mills; Gregory A Talavera; John P Elder; Linda C Gallo
Journal:  J Community Health       Date:  2012-04

5.  Using colorectal trends in the U.S. to identify unmet primary care needs of vulnerable populations.

Authors:  Patricia Y Miranda; Michelle Johnson-Jennings; Wassim Tarraf; Patricia González; William A Vega; Hector M González
Journal:  Prev Med       Date:  2012-05-30       Impact factor: 4.018

6.  Understanding the barriers and facilitators of colorectal cancer screening among low income immigrant hispanics.

Authors:  Lina Jandorf; Jennie Ellison; Cristina Villagra; Gary Winkel; Alejandro Varela; Zeida Quintero-Canetti; Anabella Castillo; Linda Thélémaque; Sheba King; Katherine Duhamel
Journal:  J Immigr Minor Health       Date:  2010-08

7.  Low uptake of periodic health examinations in the Kingdom of Saudi Arabia, 2013.

Authors:  Charbel El Bcheraoui; Marwa Tuffaha; Farah Daoud; Mohammad A AlMazroa; Mohammad Al Saeedi; Ziad A Memish; Mohammed Basulaiman; Abdullah A Al Rabeeah; Ali H Mokdad
Journal:  J Family Med Prim Care       Date:  2015 Jul-Sep
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.